Drug Type Prophylactic vaccine |
Synonyms 9valent Escherichia coli vaccine Janssen, EXPEC9V, JNJ 78901563 + [3] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | Phase 3 | US | 24 Oct 2023 | |
Influenza, Human | Phase 3 | BE | 24 Oct 2023 | |
Influenza, Human | Phase 3 | CA | 24 Oct 2023 | |
Influenza, Human | Phase 3 | PL | 24 Oct 2023 | |
Urinary Tract Infections | Phase 3 | US | 30 Jun 2021 | |
Urinary Tract Infections | Phase 3 | US | 30 Jun 2021 | |
Urinary Tract Infections | Phase 3 | US | 30 Jun 2021 | |
Urinary Tract Infections | Phase 3 | US | 30 Jun 2021 | |
Urinary Tract Infections | Phase 3 | CN | 30 Jun 2021 | |
Urinary Tract Infections | Phase 3 | JP | 30 Jun 2021 |